Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mannatech, Glycoproducts split decision

This article was originally published in The Tan Sheet

Executive Summary

A federal court jury rules in favor of Glycoproducts International regarding infringement of one Mannatech patent in its Glycomannan product, but found the Riggins, Idaho-based firm infringed on a second patent for Mannatech's Ambrotose glyconutrient supplement. The jury in the U.S. District Court for the Northern District of Texas affirmed Mannatech's claim that Glycoproducts infringed on its Ambrotose trademark, the firms say May 28. Coppell, Texas-based Mannatech will pursue an injunction prohibiting Glycoproducts from producing and selling Glycomannan, as well as the reimbursement of its legal fees. Glycoproducts will oppose the injunction request...

You may also be interested in...

Mannatech prevails over Glycoproducts

A federal judge rules Glycomannan by Glycoproducts International infringed on multiple patents held by Coppell, Texas-based Mannatech, according to Mannatech. The ruling by the U.S. District Court for the Northern District of Texas also entered a broad permanent injunction against Riggins, Idaho-based Glycoproducts to make, use or sell Glycomannan in the U.S., Mannatech says July 11. Mannatech sought the injunction following a trial jury ruling that Glycoproducts had only infringed one of two patents for Mannatech's Ambrotose glyconutrient supplement (1"The Tan Sheet" June 16, 2008, In Brief)...

Health And Wellness Trademark Review 19 January, 2021

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Europe's CBD Market In 2020: Narcotic Vs Novel Food

INFOGRAPHIC: An interactive timeline of selected HBW Insight coverage of the growing European CBD dietary supplements market in 2020. The timeline covers the main events of a rollercoaster 12 months, including the European Commission’s indecision on whether to classify CBD as narcotic or novel food and how the path forward became clear in the UK.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts